Scientists confirm efficacy of a combination therapy for advanced liver cancer

Researchers from Taiwan and Japan, led by Dr Victor Kok of Kuang Tien General Hospital and Asia University Taiwan, found that when the anticancer drug sorafenib was combined with TACE, a radiological treatment procedure, patients with liver cancer had higher survival.

This result comes from the largest population-based study available on this topic and will help doctors improve existing therapies for liver cancer, which kills thousands of people worldwide.

More news:

Liberty Time Net: https://news.ltn.com.tw/news/life/breakingnews/2949245

連合新聞網: https://udn.com/news/story/7266/4109332

Central News Agency: https://udn.com/news/story/7266/4109332